Novel mechanisms of glomerular injury in primary membranous nephropathy
原发性膜性肾病肾小球损伤的新机制
基本信息
- 批准号:10618308
- 负责人:
- 金额:$ 37.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAlbuminsAnimalsAntibodiesAntigensAutoantibodiesBasement membraneCell CommunicationCellsCharacteristicsClinicalComplement 3aComplement 3dComplement ActivationComplement InactivatorsComplement Membrane Attack ComplexCytoskeletonDataDepositionDevelopmentDiseaseDisease remissionEndothelial CellsEndotheliumExposure toExtravasationFiltrationFunctional disorderFutureGlomerulonephritisHumanImmuneImmunoglobulin GImpairmentIn VitroInjuryIntervention TrialInulinKidneyKidney DiseasesKidney FailureKnockout MiceMAP Kinase GeneMMP9 geneMediatingMembraneMembranous GlomerulonephritisModelingModificationMolecularMultiple TraumaMusNF-kappa BNephrotic SyndromePathogenesisPathway interactionsPatientsPermeabilityPharmacologic SubstancePhenotypePhospholipase A2PlacebosPlayProductionProteinsProteinuriaRandomized, Controlled TrialsRattusReceptor SignalingRoleSerumSignal TransductionSnailsSystemTestingThrombospondinsWorkantagonistcell injurycomplement C3 precursorexperimental studyglomerular basement membraneglomerular endotheliumglomerular filtrationglomerulosclerosishuman diseasein vivonoveloverexpressionpharmacologicpodocytepre-clinicalpreventreceptorrenal damageslit diaphragmtherapeutic targettooltranslational studyurinary
项目摘要
Novel mechanisms of glomerular injury in primary membranous nephropathy
Primary membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults. Injury is
initiated by the deposition of circulating auto-antibodies against podocyte antigens in the subepithelial space of
the basement membrane, leading to complement activation and formation of the C5b-9 membrane attack
complex (MAC). MAC-mediated sublytic injury is thought to cause podocyte damage and glomerular disruption.
However, a randomized controlled trial showed no benefit of anti-C5 antibody in disease remission in patients
with MN, suggesting that other MAC-independent mechanisms apply. Studies on MN pathophysiology have
been limited by the lack of reliable in vitro systems. We generated a new glomerulus-on-a-chip platform that we
will use as a tool to assess alternative mechanisms of injury in MN. Preliminary data suggest that complement
activation leads to C3a/C3aR signaling in podocytes, which induces loss of glomerular permselectivity due
to SNAIL-mediated signaling. Moreover, challenging current assumption in MN, we have found that
MN-serum leads to C3a/C3aR signaling also in glomerular endothelial cells and induces overexpression of
MMP9, thus suggesting a role of this signaling in regulating glomerular basement membrane-cell interaction.
These effects are prevented by a C3aR antagonist, suggesting the direct involvement of C3a in podocyte and
GEC damage and in glomerular basement membrane (GBM) degradation. Therefore, based on our
preliminary data we hypothesize that C3a/C3aR signaling not only plays a critical role in podocyte damage
but exert its effects also on GEC, leading to disruption of glomerular filtration barrier and loss of
permselectivity. To test our hypothesis, we will investigate the effects of C3a signaling, its mechanism(s) of
action and its role in GBM degradation both in vitro and in vivo. If confirmed, our findings will not only provide
novel evidence that multiple injury mechanisms are in play in PMN but will also inform us about potential
therapeutic targets that could prove useful for the development of new treatments for MN and other
proteinuric diseases.
原发性膜性肾病肾小球损伤的新机制
原发性膜性肾病(MN)是成人肾病综合征的最常见原因。伤害是
由针对足细胞抗原的循环自身抗体在足细胞上皮下空间的沉积引起
基底膜,导致补体激活并形成 C5b-9 膜攻击
复杂(MAC)。 MAC 介导的亚溶解性损伤被认为会导致足细胞损伤和肾小球破坏。
然而,一项随机对照试验表明抗 C5 抗体对患者疾病缓解没有益处
与 MN,表明其他独立于 MAC 的机制也适用。 MN病理生理学研究
由于缺乏可靠的体外系统而受到限制。我们生成了一个新的肾小球芯片平台
将用作评估 MN 损伤替代机制的工具。初步数据表明,补充
激活导致足细胞中的 C3a/C3aR 信号传导,从而导致肾小球通透选择性丧失
SNAIL 介导的信号传导。此外,挑战当前 MN 的假设,我们发现
MN 血清也在肾小球内皮细胞中导致 C3a/C3aR 信号转导,并诱导
MMP9,因此表明该信号传导在调节肾小球基底膜-细胞相互作用中的作用。
这些作用可被 C3aR 拮抗剂阻止,表明 C3a 直接参与足细胞和
GEC 损伤和肾小球基底膜 (GBM) 降解。因此,根据我们的
根据初步数据,我们假设 C3a/C3aR 信号传导不仅在足细胞损伤中发挥关键作用
但也会对 GEC 产生影响,导致肾小球滤过屏障破坏和肾小球滤过屏障丧失
渗透选择性。为了检验我们的假设,我们将研究 C3a 信号传导的影响及其机制
作用及其在体外和体内 GBM 降解中的作用。如果得到证实,我们的发现不仅将提供
新证据表明多种损伤机制在 PMN 中发挥作用,但也将告诉我们潜在的可能性
可能被证明对开发 MN 和其他疾病新疗法有用的治疗靶点
蛋白尿疾病。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The 2019 and 2021 International Workshops on Alport Syndrome.
- DOI:10.1038/s41431-022-01075-0
- 发表时间:2022-05
- 期刊:
- 影响因子:0
- 作者:Daga S;Ding J;Deltas C;Savige J;Lipska-Ziętkiewicz BS;Hoefele J;Flinter F;Gale DP;Aksenova M;Kai H;Perin L;Barua M;Torra R;Miner JH;Massella L;Ljubanović DG;Lennon R;Weinstock AB;Knebelmann B;Cerkauskaite A;Gear S;Gross O;Turner AN;Baldassarri M;Pinto AM;Renieri A
- 通讯作者:Renieri A
Decay-Accelerating Factor Restrains Complement Activation and Delays Progression of Murine cBSA-Induced Membranous Nephropathy.
- DOI:10.34067/kid.0000000000000122
- 发表时间:2023-06-01
- 期刊:
- 影响因子:0
- 作者:Budge KL;Verlato A;Bin S;Salem FE;Perin L;La Manna G;Zaza G;Fiaccadori E;Cantarelli C;Cravedi P
- 通讯作者:Cravedi P
Generation of a Glomerular Filtration Barrier on a Glomerulus-on-a-Chip Platform.
- DOI:10.1007/978-1-0716-1693-2_8
- 发表时间:2021-09
- 期刊:
- 影响因子:0
- 作者:L. Perin;Stefano Da Sacco
- 通讯作者:L. Perin;Stefano Da Sacco
C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy.
C3aR 启动的信号传导是膜性肾病足细胞损伤的关键机制。
- DOI:10.1172/jci.insight.172976
- 发表时间:2024
- 期刊:
- 影响因子:8
- 作者:Zhang,Qi;Bin,Sofia;Budge,Kelly;Petrosyan,Astgik;Villani,Valentina;Aguiari,Paola;Vink,Coralien;Wetzels,Jack;Soloyan,Hasmik;LaManna,Gaetano;Podestà,ManuelAlfredo;Molinari,Paolo;Sedrakyan,Sargis;Lemley,KevinV;DeFilippo,Roger
- 通讯作者:DeFilippo,Roger
Emerging Technologies to Study the Glomerular Filtration Barrier.
- DOI:10.3389/fmed.2021.772883
- 发表时间:2021
- 期刊:
- 影响因子:3.9
- 作者:Gong E;Perin L;Da Sacco S;Sedrakyan S
- 通讯作者:Sedrakyan S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stefano Da Sacco其他文献
Stefano Da Sacco的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stefano Da Sacco', 18)}}的其他基金
Mechanisms involved in podocyte damage in Alport Syndrome
阿尔波特综合征足细胞损伤的机制
- 批准号:
10503338 - 财政年份:2022
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms involved in podocyte damage in Alport Syndrome
阿尔波特综合征足细胞损伤的机制
- 批准号:
10677742 - 财政年份:2022
- 资助金额:
$ 37.24万 - 项目类别:
Novel mechanisms of glomerular injury in primary membranous nephropathy
原发性膜性肾病肾小球损伤的新机制
- 批准号:
10176476 - 财政年份:2020
- 资助金额:
$ 37.24万 - 项目类别:
Novel mechanisms of glomerular injury in primary membranous nephropathy
原发性膜性肾病肾小球损伤的新机制
- 批准号:
10433930 - 财政年份:2020
- 资助金额:
$ 37.24万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Novel therapies for obesity- or diabetes-related lymphatic dysfunction
肥胖或糖尿病相关淋巴功能障碍的新疗法
- 批准号:
10602589 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
- 批准号:
10638267 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
"REAL Answers" (Registry Expansion Analyses to Learn)
“真正的答案”(注册扩展分析以学习)
- 批准号:
10566762 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Overcoming pressure ulcers with engineered hormones and stem cells
用工程激素和干细胞克服压疮
- 批准号:
10821146 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
MRI-Based Renal Oximetry in Early Diabetic Kidney Disease
基于 MRI 的肾血氧饱和度在早期糖尿病肾病中的应用
- 批准号:
10593684 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别: